Journal of Obstetrics and Gynaecology (J Obstet Gynaecol)

Publisher: Informa Healthcare

Journal description

Journal of Obstetrics and Gynaecology represents an established forum for the entire field of obstetrics and gynaecology, publishing a broad range of original, peer-reviewed papers, from scientific and clinical research to reviews relevant to practice and case reports. It also includes occasional supplements on clinical symposia. The journal continues to attract a world-wide readership thanks to the emphasis on practical applicability and its excellent record of drawing on an international base of authors. (online)

Current impact factor: 0.60

Impact Factor Rankings

2015 Impact Factor Available summer 2015
2013 / 2014 Impact Factor 0.604
2012 Impact Factor 0.546
2011 Impact Factor 0.542
2010 Impact Factor 0.44
2009 Impact Factor 0.431

Impact factor over time

Impact factor

Additional details

5-year impact 0.00
Cited half-life 5.30
Immediacy index 0.02
Eigenfactor 0.00
Article influence 0.00
Website Journal of Obstetrics and Gynaecology website
Other titles Journal of obstetrics and gynaecology (Online), Journal of obstetrics and gynecology
ISSN 1364-6893
OCLC 37915558
Material type Document, Periodical, Internet resource
Document type Internet Resource, Computer File, Journal / Magazine / Newspaper

Publisher details

Informa Healthcare

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author cannot archive a post-print version
  • Restrictions
    • 12 months embargo
  • Conditions
    • On author's personal website or institution website
    • Publisher copyright and source must be acknowledged
    • On a non-profit server
    • Must link to publisher version
    • Publisher's version/PDF cannot be used
    • NIH funded authors may post articles to PubMed Central for release 12 months after publication
    • Wellcome Trust authors may deposit in Europe PMC after 6 months
  • Classification
    ​ yellow

Publications in this journal

  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of the study was to evaluate sexual functions of pregnant women and to determine the factors affecting their sexual function. The cross-sectional study recruited 286 pregnant women from a hospital. To collect data, ‘Patient Information Form’, ‘State Anxiety Inventory’ and ‘Female Sexual Function Index’ were used. The mean age of women was 29.15 ± 4.85 and 77.6% of them presented with sexual dysfunction. Having partner at advanced age, a history of miscarriage, a history of health problem during previous pregnancy and a high level of anxiety were found to be factors negatively affecting sexual function. Health professionals should be aware of a number of risk factors that may contribute to sexual dysfunction in pregnant women.
    Journal of Obstetrics and Gynaecology 02/2015; DOI:10.3109/01443615.2015.1006596
  • [Show abstract] [Hide abstract]
    ABSTRACT: We present the experience of a tertiary referral hospital in Greece, evaluating obstetric and perinatal outcomes among teenage and average maternal age (AMA) women. We retrospectively assessed all singleton pregnancies during a twelve-month period (January–December 2012). A total of 1,704 cases were reviewed and divided into two groups: one of AMA mothers (20–34 years old) (1,460 women) and the other of teenage mothers (12–19 years old) (244 women). We observed significantly higher incidence rates of preterm births (p < 0.001), preterm premature rupture of the membranes (p < 0.001), gestational hypertension (p < 0.001), preeclampsia (p = 0.043) and Apgar scores < 7 at 5 min (p = 0.015) among teenage mothers. Antenatal surveillance was decreased among teenage mothers (p < 0.001), while rates of anaemia were higher (p < 0.001). Teenage pregnancy is accompanied by significant antenatal and perinatal complications that need specific obstetrical attention. Obstetricians should be aware of these complications in order to ameliorate the antenatal outcome of childbearing teenagers.
    Journal of Obstetrics and Gynaecology 12/2014; DOI:10.3109/01443615.2014.991285
  • Journal of Obstetrics and Gynaecology 12/2014; DOI:10.3109/01443615.2014.987116
  • [Show abstract] [Hide abstract]
    ABSTRACT: A 57-year-old menopausal woman (last period 13 months ago), G3P2, with a history of a complete molar pregnancy 3 years ago (confirmed in our institution Pathology department and latter reconfirmed by a gynaecological pathology expert of another institution), complaining of stress urinary incontinence and evidence of low anterior vaginal wall bulging at physical examination, was admitted for surgical repair of anterior pelvic organ prolapse, admitted as a urethrocele/cystocele. Intraoperatively, aft er anterior vaginal wall incision, a periurethral hard lesion was found and biopsied. The histological examination revealed: intermediate trophoblastic cells with nuclear atypia, invading the vascular spaces. Immunohistochemically, the tumour cells showed strong diffuse positivity for human placental lactogenic hormone (hPL), focal weak positivity for human chorionic gonadotropin ( β-hCG) and α-inhibin; the Ki-67 proliferative index was about 12%, supporting the diagnosis of placental site trophoblastic tumour (PSTT). Pelvic magnetic resonance imaging (MRI) was performed revealing diffuse uterine adenomyosis, without any other uterine or adnexal morphological changes; there were no enlarged retroperitoneal or pelvic lymph nodes. On T2-weighted images, a right-sided periurethral solid lesion, with moderate hypersignal was shown, not well-demarcated from the urethral wall. On dynamic T1-weighted post-contrast sequences, the lesion enhanced slightly and on diffusion-weighted images showed high signal, with low signal on an ADC map, imaging features related to water restriction, typical of malignant lesions. The patient was treated by total hysterectomy with bilateral salpingo-oophorectomy and excision of the periurethral lesion. Histological examination failed to show any residual uterine tumour. After surgery, the β-hCG level in the serum was found to be 2.8 mIU/ml. The final diagnosis in this patient was a PSTT metastasis.
    Journal of Obstetrics and Gynaecology 11/2014; Nov(10):1-2. DOI:10.3109/01443615.2014.968108
  • Journal of Obstetrics and Gynaecology 08/2014;
  • Journal of Obstetrics and Gynaecology 08/2014; 35(2). DOI:10.3109/01443615.2014.940300
  • [Show abstract] [Hide abstract]
    ABSTRACT: This study aims at identifying predictors of asymptomatic bacteriuria (AB) among pregnant women in a low-resource setting, with the intent of recommending a guideline for screening during antenatal care. A total of 266 healthy pregnant women were antenatally recruited after informed consent. They had routine antenatal investigations, a 1 h 50-g oral glucose tolerance test and quantitative urine culture and sensitivity. The data collected were analysed using statistical software package SPSS v. 17. Prevalence of AB was 23 (8.6%). Escherichia coli was the commonest isolate (6, 26.1%), closely followed by Staphylococcus aureus (5, 21.7%). AB was commoner among patients aged 25-34 years, of low parity and higher education. Blood group B- rhesus-positive significantly predicts the likelihood of developing AB in pregnancy (adjusted OR: 0.36; 95% CI: 0.14-0.96). We conclude that blood group B-rhesus-positive in association with other patients' characteristics, such as age 25-34 years, low parity and higher education could form guidelines for a screening algorithm in our environment.
    Journal of Obstetrics and Gynaecology 07/2014; DOI:10.3109/01443615.2014.935724
  • [Show abstract] [Hide abstract]
    ABSTRACT: The objective of this study was to compare the safety and efficacy of atosiban and ritodrine in the treatment of threatened preterm labour (TPL) and to analyse the predictive factors of preterm delivery. We retrospectively sampled data on 380 women hospitalised for TPL (24-35 weeks' gestation), in our clinic between 2004 and 2007. All were subjected to tocolysis with ritodrine and/or atosiban. Data were analysed using R (version 2.12.1), considering p < 0.05 as significant. We had 69 women treated with atosiban, 242 treated with ritodrine and 69 treated with ritodrine changed for atosiban, if adverse effects occurred. In the multivariate logistic regression, the use of atosiban vs ritodrine does not play any role in delaying delivery after 48 h or 7 days, whereas the cervical change at the digital examination, high contractions pre/post-therapy ratio, pPROM, cervical length and fibronectin result as predictive factors for both delivery before 48 h or 7 days. Maternal adverse drug effects were significantly more frequent in patients treated with ritodrine, and one single case of pulmonary oedema was observed. We found fewer side-effects in the atosiban than in the ritodrine group and no difference in efficacy. Moreover, the most predictive factors for preterm delivery were fibronectin test, pPROM, digital vaginal examination and uterine contraction persistence. We believe that predictive capacity of these tests could give the opportunity for targeting therapy and limiting drug side-effects and cost.
    Journal of Obstetrics and Gynaecology 06/2014; 34(8):1-6. DOI:10.3109/01443615.2014.930094
  • Journal of Obstetrics and Gynaecology 06/2014; DOI:10.3109/01443615.2014.930095
  • Journal of Obstetrics and Gynaecology 06/2014; DOI:10.3109/01443615.2014.930102
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to explore the risk factors and how to avoid re-laparotomy after caesarean delivery and to present the experience of a university tertiary care referral hospital. The study comprised of 2,000 caesarean deliveries, among which re-laparotomy was needed in 18 patients (0.9). The study found that 16 of the 18 cases that needed re-laparotomy had previous caesarean sections (CS) and 9/18 had placenta praevia. The main indication of the procedure was internal haemorrhage (haemoperitoneum) (12/18, 66.6%). Significant haemoperitoneum of > 2 litres was reported in six cases (33.3%). Maternal mortality occurred in 3/18 (16.6%) patients. The uterus was preserved in most patients (15 patients, 83.3%). A total of 12 patients needed re-suturing of the uterine incision; 10 patients had bilateral uterine artery ligation; and four patients had bilateral internal iliac artery ligation. Uterine compression B-Lynch suturing was needed in five patients with uterine atony. Six patients (33.3%) were admitted to the intensive care unit (ICU) and were discharged well. Re-laparotomy after caesarean delivery has many risk factors leading to postoperative haemorrhage. Early signs, such as tachycardia and hypotension must be closely monitored to allow early interference and to avoid morbidity and mortality related to late re-laparotomy.
    Journal of Obstetrics and Gynaecology 06/2014; DOI:10.3109/01443615.2014.929644
  • Journal of Obstetrics and Gynaecology 06/2014; 34(7):1-2. DOI:10.3109/01443615.2014.920803
  • Journal of Obstetrics and Gynaecology 06/2014; 34(8):1-2. DOI:10.3109/01443615.2014.923820
  • [Show abstract] [Hide abstract]
    ABSTRACT: The aim of this study was to validate the efficacy of a protocol for the management of infants born to colonised mothers with Group B Streptococcus (GBS). We studied a cohort of newborns admitted at the A. Gemelli University Hospital between May 2006 and December 2009. A total of 1,108 were newborns of mothers with GBS; 178 were children of mothers with unknown GBS status. Newborns were managed according to the care protocol in use at our division. Infected infants were born to mothers who underwent inadequate intrapartum antibiotic prophylaxis (IAP). No mother with complete IAP had an infected newborn. The incidence of invasive GBS infection in newborns of mothers with GBS was 0.4% and in newborns of mothers with unknown GBS status was 2.2%. Only 17.4% of newborns of mothers with GBS had risk factors. The complete IAP should always be performed regardless of the presence or the absence of risk factors. The care protocol applied offers successful management of the newborns of mothers with GBS, based on the correct execution of IAP, considering as a primary risk factor, the gestational age of < 35 weeks.
    Journal of Obstetrics and Gynaecology 06/2014; 34(8):1-6. DOI:10.3109/01443615.2014.920796
  • Journal of Obstetrics and Gynaecology 06/2014; DOI:10.3109/01443615.2014.925860